financetom
Business
financetom
/
Business
/
Boston Scientific Insider Sold Shares Worth $570,511, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Boston Scientific Insider Sold Shares Worth $570,511, According to a Recent SEC Filing
Sep 5, 2024 1:40 AM

05:31 PM EDT, 09/03/2024 (MT Newswires) -- Wendy Carruthers, Executive Vice President, Human Resources, on September 03, 2024, sold 6,983 shares in Boston Scientific ( BSX ) for $570,511. Following the Form 4 filing with the SEC, Carruthers has control over a total of 37,468 shares of the company, with 37,468 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/885725/000122520824008333/xslF345X05/doc4.xml

Price: 81.12, Change: -0.02, Percent Change: -0.02

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
NTSB sanctions Boeing over release of 737 MAX investigation details
NTSB sanctions Boeing over release of 737 MAX investigation details
Jun 27, 2024
WASHINGTON/SEATTLE, June 27 (Reuters) - The U.S. National Transportation Safety Board said on Thursday it was sanctioning Boeing ( BA ) for disclosing non-public details of an ongoing investigation into a 737 MAX mid-air emergency and would refer its conduct to the Justice Department. The NTSB said Boeing ( BA ) had blatantly violated the agency's investigative regulations by providing...
Walgreens Cuts Full-Year Earnings Outlook on 'Challenging' Pharmacy, Consumer Trends
Walgreens Cuts Full-Year Earnings Outlook on 'Challenging' Pharmacy, Consumer Trends
Jun 27, 2024
09:19 AM EDT, 06/27/2024 (MT Newswires) -- Walgreens Boots Alliance ( WBA ) slashed its full-year earnings outlook on Thursday amid challenging pharmacy industry trends and a worsening retail environment, as the drug-store operator plans to close some underperforming US stores after quarterly profit missed market estimates. The company now anticipates adjusted earnings to be in a range of $2.80...
Coherus BioSciences to Sell Yusimry to Hong Kong King-Friend Industrial in $40 Million Cash Transaction
Coherus BioSciences to Sell Yusimry to Hong Kong King-Friend Industrial in $40 Million Cash Transaction
Jun 27, 2024
09:21 AM EDT, 06/27/2024 (MT Newswires) -- Coherus BioSciences ( CHRS ) said Thursday it had agreed to sell its proprietary drug Yusimry to Hong Kong King-Friend Industrial for $40 million cash upfront. HKF's subsidiary Meitheal Pharmaceuticals will continue to commercialize Yusimry, a treatment for various types of arthritis, in the US, Coherus said. Coherus said the move was part...
Sprinklr Supports Provides Support for Snapchat Public Profiles for Businesses
Sprinklr Supports Provides Support for Snapchat Public Profiles for Businesses
Jun 27, 2024
09:22 AM EDT, 06/27/2024 (MT Newswires) -- Sprinklr ( CXM ) said Thursday it is providing support for Snap's (SNAP) Snapchat Public Profiles for Businesses in Sprinklr Marketing. Sprinklr ( CXM ) said brands can post Snapchat Stories, publish Spotlight Content and promote this organic content with ads in Sprinklr ( CXM ), becoming the first Snapchat partner that enables...
Copyright 2023-2026 - www.financetom.com All Rights Reserved